SAB Biotherapeutics (SABS) Tax Rate (2022)

SAB Biotherapeutics' (SABS) quarterly Tax Rate came in at 1.9% in Q2 2022, down 77.85% on a QoQ basis from 8.56% in Q1 2022.

SAB Biotherapeutics (SABS) Tax Rate (2022) Analysis & Trends

SAB Biotherapeutics (SABS) has 1 years of Tax Rate data on file, last reported at 1.9% in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	SAB Biotherapeutics	308.92 Mn	308.92 Mn	-	-

Download Data